Join leading cancer researchers on Thursday, October 27, for Moving Breast Cancer Treatments Forward, a symposium that tackles how we can better diagnose and treat cancer.
The morning panel will focus on targeting therapeutic vulnerabilities of metastatic breast cancer cells and the afternoon panel will focus on spatial analysis of breast cancer heterogeneity and microenvironmental interactions.
One of the world’s leading cancer researchers, Jorge Reis-Filho, MD, PhD, with Memorial Sloan Kettering Cancer Center, will deliver the Jayne Koskinas Memorial Lecture. Early registration is available to JKTG Foundation newsletter subscribers and friends.
“By convening a distinguished group to talk possibilities, discoveries, and the research behind both, we get one step closer to better health care for those diagnosed with cancer,” said Ted Giovanis, founder and president of JKTG Foundation.
“The Foundation strongly believes in the power of collaboration and events such as this give an opportunity for traditionally siloed research to creatively question traditional thinking and transform how we diagnose and treat cancer.”
JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Social Determinants of Health (SDoH) is all the rage as far as evaluating health. Stable housing, education, access to transportation, polluted water/air, etc. are all an important part of the discussion.
Medicare Part C, sometimes called Medicare Advantage, is touted as the efficient way to deliver quality care to enrollees. As someone on Medicare, I am not in a Medicare Part C. Why? Because I know better.